CSS
KRRO icon

Cubist Systematic Strategies’s Korro Bio KRRO Stock Holding History

Cubist Systematic Strategies’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-258
Closed -$23K – 4428
2022
Q3 		$23K Buy
+258
New +$26.2K ﹤0.01% 4226
2022
Q2 		– Sell
-470
Closed -$50K – 4451
2022
Q1 		$50K Buy
+470
New +$89.8K ﹤0.01% 3376
2021
Q4 		– Sell
-305
Closed -$108K – 3545
2021
Q3 		$108K Sell
305
-1,089
-78% -$429K ﹤0.01% 2730
2021
Q2 		$694K Sell
1,394
-170
-11% -$83K 0.01% 1796
2021
Q1 		$743K Buy
+1,564
New +$3.04M 0.01% 1722

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cubist Systematic Strategies's KRRO Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Korro Bio (KRRO) in Q4 2022, closing a stake of 258 shares — an estimated $23K sold.

Cubist Systematic Strategies first reported a position in KRRO in Q1 2021 and held it in 5 quarters. The position peaked at $743K in Q1 2021. 49 funds tracked by Wall St. Rank hold KRRO as of Q4 2022.

  • Cubist Systematic Strategies reported no remaining Korro Bio position as of Q4 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 258 Korro Bio shares in Q4 2022, an estimated $23K.
  • Cubist Systematic Strategies first reported a position in Korro Bio in Q1 2021 and held it in 5 quarters.
  • Cubist Systematic Strategies's Korro Bio position peaked at $743K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Korro Bio as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.